Rx (Prescription Medicine)
USD $ 30.00
Osteofos 70 Tablet 4 是一种主要用于管理和治疗骨质疏松及其他骨相关疾病的药物。其活性成分通常为一种双膦酸盐，如阿仑酸钠，在强化骨骼、降低骨折风险方面起着关键作用。双膦酸盐通过抑制破骨细胞的活性发挥作用，破骨细胞是分解骨组织的细胞。通过减缓骨吸收，Osteofos 70 Tablet 4 有助于提高骨矿物密度并改善骨组织结构，使骨骼更不易发生骨折。该药物适用于绝经后骨质疏松、男性骨质疏松、糖皮质激素诱导性骨质疏松，也用于帕金森病（Paget’s disease of bone）。通常的用法为每周一次，遵医嘱服用一片。必须空腹服用，用一杯清水服用，并在服药前至少30分钟内避免进食、饮用任何饮料或其他药物。服药后需保持直立姿势至少30分钟，以防止食管刺激。常见的副作用可能包括胃肠道问题，如心口灼灼感、恶心或腹痛。罕见的严重副作用可能包括颚骨坏死或不寻常的股骨骨折。始终请咨询医生，获取个性化建议，并在开始或停止任何药物前先与医生沟通。将Osteofos 70 Tablet 4 存放于室温，避免潮湿和高温。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Alendronate 70 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
